Why have a Breast Cancer Summit?

mCancerPartner recently sat down with Daniel Hayes, M.D., the Stuart B. Padnos Professor of Breast Cancer Research at the U-M Comprehensive Cancer Center, to discuss the creation of the Breast Cancer Summit, a day-long community event highlighting breast cancer prevention, treatment and survival.

Daniel F. Hayes, MD

Daniel F. Hayes, MD

mCancer Partner: Not only do you participate in the Cancer Center’s Breast Cancer Summit as a speaker, but I you championed its formation. Why do you feel it’s important for our community to have access to this breast cancer event?

Dr. Hayes: The U-M faculty presenting at this summit are a distinguished group. It isn’t every day that a community has direct access to so many nationally and internationally recognized breast cancer experts. To explain, we at the Cancer Center have more than four decades of breast cancer experience – screening, prevention, diagnosis and treatment. We also were one of the first cancer centers in the country to have a multidisciplinary weekly tumor board for our breast cancer patients; ours began 25 years ago. As a result, we have world leaders in every facet of breast cancer research and care – surgery, radiation oncology, pathology, imaging and medical oncology.  Many of our faculty are involved in setting national guidelines for clinical care. I think it is pretty rare for so many breast cancer specialists of this caliber to be in one place, at the same time, and accessible to patients, families, survivors and their supporters locally. Continue reading

Your invitation to Ann Arbor’s Breast Cancer Summit

A community event

If you are a breast cancer survivor, caregiver or member of the general public concerned about breast cancer, please join us for a Breast Cancer Summit on Saturday, April 20, 2013 at Washtenaw Community College. The summit bridges the gap between our community and academic medicine by giving the audience a chance to ask questions and interact with U-M breast cancer specialists. Many are leaders nationally in the fight against breast cancer.

Maria Lyzen, right, and Ruth Freedman lead the Cancer Center's Breast Cancer Advisory and Advocacy Committee.

Maria Lyzen, right, and Ruth Freedman lead the Cancer Center’s Breast Cancer Advisory and Advocacy Committee.

The summit was organized through encouragement from the U-M Comprehensive Cancer Center’s breast cancer advocates. They feel the summit is a way to let the community know that the U-M breast cancer specialists are collaborative and multidisciplinary. Panel discussions and a mock tumor board will give the audience a first-hand look at how these leading oncologists work together on behalf of their patients. They will also give an update on the latest breast cancer research at Michigan and nationally, showing what has been learned and how vital research donations are to these research advances.

The summit will cover:

  • cancer prevention
  • screening
  • treatment
  • research, including clinical trials
  • survivorship
  • genetic risk Continue reading

Male breast cancer: Men can and do get it

Risk factors include age, family history and inherited gene mutations

male breast cancer

Most male breast cancer is found in men between the ages of 60 and 70.

 

While we tend to think of breast cancer as a women’s disease, men can develop breast cancer, too. The group is small—fewer than 1% of all breast cancer cases. Most male breast cancer is found in men between the ages of 60 and 70.

Today, survival is similar for both men and women when their stage at diagnosis is the same. But men are less likely than women to notice changes in their breasts or chest, or to mention these changes to their doctors. As a result, male breast cancer is more often diagnosed at a later stage, when a cure is less likely. Continue reading